# EDGAR Filing Document

**Accession Number:** 0001844862
**File Stem:** 0001104659-25-106583
**Filing Date:** 2025-11
**Character Count:** 130676
**Document Hash:** ba07ed48e93077ff2114e42d1788eb0f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-106583.hdr.sgml**: 20251105

**ACCESSION NUMBER**: 0001104659-25-106583

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251105

**DATE AS OF CHANGE**: 20251105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Solid Power, Inc.
- **CENTRAL INDEX KEY:** 0001844862
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 861888095
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40284
- **FILM NUMBER:** 251451592

**BUSINESS ADDRESS:**
- **STREET 1:** 486 S. PIERCE AVE., SUITE E
- **CITY:** LOUISVILLE
- **STATE:** CO
- **ZIP:** 80027
- **BUSINESS PHONE:** (303) 219-0720

**MAIL ADDRESS:**
- **STREET 1:** 486 S. PIERCE AVE., SUITE E
- **CITY:** LOUISVILLE
- **STATE:** CO
- **ZIP:** 80027

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Decarbonization Plus Acquisition Corp III
- **DATE OF NAME CHANGE:** 20210208

?xml version='1.0' encoding='ASCII'? SOLID POWER, INC._September 30, 2025

[**Table of Contents**](#TOC)

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the quarterly period ended September 30, 2025

or

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from _______ to _______

Commission file number: **001-40284**

![Graphic](sldp-20250930x10q004.gif)

**SOLID POWER, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **86-1888095** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
| **486 S. Pierce Ave., Suite E** |  |
| **Louisville, Colorado** | **80027** |
| (Address of principal executive offices) | (Zip Code) |

---

**(303) 219-0720**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| **Common stock, par value $0.0001 per share** | **SLDP** | **The Nasdaq Stock Market LLC** |
| **Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50** | **SLDPW** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

191,023,570 shares of common stock were issued and outstanding as of November 3, 2025.

------

[**Table of Contents**](#TOC)

**SOLID POWER, INC.**

**FORM 10-Q**

**Table of Contents**

---

| | | |
|:---|:---|:---|
| [**PART I. FINANCIAL INFORMATION**](#PARTIFINANCIALINFORMATION_263805) | [**PART I. FINANCIAL INFORMATION**](#PARTIFINANCIALINFORMATION_263805) |  |
| &nbsp;&nbsp;&nbsp;[Item 1.](#Item1FinancialStatements_212562) | [Financial Statements](#Item1FinancialStatements_212562) | 4 |
| &nbsp;&nbsp;&nbsp;[Item 2.](#Item2ManagementsDiscussion_864112) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#Item2ManagementsDiscussion_864112) | 23 |
| &nbsp;&nbsp;&nbsp;[Item 3.](#Item3QuantitativeandQualitative_380849) | [Quantitative and Qualitative Disclosures About Market Risk](#Item3QuantitativeandQualitative_380849) | 30 |
| &nbsp;&nbsp;&nbsp;[Item 4.](#Item4ControlsandProcedures_2056) | [Controls and Procedures](#Item4ControlsandProcedures_2056) | 31 |
| [**PART II. OTHER INFORMATION**](#PARTIIOTHERINFORMATION_132178) | [**PART II. OTHER INFORMATION**](#PARTIIOTHERINFORMATION_132178) |  |
| &nbsp;&nbsp;&nbsp;[Item 1.](#Item1LegalProceedings_581533) | [Legal Proceedings](#Item1LegalProceedings_581533) | 31 |
| &nbsp;&nbsp;&nbsp;[Item 1A.](#Item1ARiskFactors_56269) | [Risk Factors](#Item1ARiskFactors_56269) | 31 |
| &nbsp;&nbsp;&nbsp;[Item 6.](#Item6Exhibits_4233) | [Exhibits](#Item6Exhibits_4233) | 32 |
| [**Signatures**](#SIGNATURE_99582) |  | 33 |

---

**Cautionary Note Regarding Forward-Looking Statements**

This Quarterly Report on Form 10-Q (this "Report") contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. References in this Report to "Solid Power," "the Company," "we," "us," and "our" refer to Solid Power, Inc. (f/k/a Decarbonization Plus Acquisition Corporation III) and its consolidated subsidiaries. We have based these forward-looking statements on our current expectations and projections about future events. All statements, other than statements of present or historical fact included in this Report, regarding our future financial performance, strategy, expansion plans, including plans related to the expansion of our electrolyte production capabilities, market opportunity, operations, and operating results; estimated revenues or losses; projected costs; future prospects; and plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "will," "expect," "plan," "anticipate," "intend," "believe," "estimate," "continue," "project," or the negative of such terms or other similar expressions. These forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this Report. We caution you that the forward-looking statements contained herein are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond our control.

In addition, we caution you that the forward-looking statements regarding the Company contained in this Report are subject to the following factors:

● risks relating to the uncertainty of the success of our research and development efforts, including our ability to achieve the technological objectives or results that our partners require and our ability to commercialize our technology in advance of competing technologies and our competitors;

● risks relating to our status as a research and development stage company with a history of financial losses with an expectation of incurring significant expenses and continuing losses for the foreseeable future, including execution of our business plan and the timing of expected business milestones;

● risks relating to the non-exclusive nature of our partnerships, our ability to secure new business relationships, and our ability to manage these relationships;

● our ability to negotiate and execute commercial agreements with our partners and customers on commercially reasonable terms;

[**Table of Contents**](#TOC)

● broad market adoption of EVs and other technologies where we are able to deploy our technology, if developed successfully;

● our success attracting and retaining our executive officers, key employees, and other qualified personnel;

● our ability to protect and maintain our intellectual property, including in jurisdictions outside of the United States;

● our ability to secure government contracts and grants, changes in government priorities with respect to our government contracts and grants or government funding reductions or delays, and the availability of government subsidies and economic incentives;

● delays in the construction and operation of facilities that meet our short-term research and development and long-term electrolyte production requirements;

● changes in applicable laws or regulations;

● risks relating to our information technology infrastructure and data security breaches;

● risks relating to other economic, business, or competitive factors in the United States and other jurisdictions, including supply chain interruptions and changes in market conditions, and our ability to manage these risks and uncertainties; and

● those factors discussed in "Part I, Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K") and in "Part II, Item 1A. Risk Factors" in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the "Q2 Form 10-Q"), as such descriptions may be updated or amended in future filings we make with the Securities and Exchange Commission ("SEC").

We caution you that the foregoing list does not contain all of the risks or uncertainties that could affect the Company.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, operating results, financial condition and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors, including those described in "Part I, Item 1A. Risk Factors" in the 2024 Form 10-K and in "Part II, Item 1A. Risk Factors" in the Q2 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Moreover, the forward-looking statements made in this Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Report to reflect events or circumstances after the date of this Report or to reflect new information or the occurrence of unanticipated events, except as required by law. You should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

**TRADEMARKS** 

Our logo and trademark appearing in this Report and the documents incorporated by reference herein are our property. This document and the documents incorporated by reference herein contain references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Report may appear without the® or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies.

[**Table of Contents**](#TOC)

**MARKET AND INDUSTRY DATA**

We obtained the industry and market data used throughout this Report or any documents incorporated herein by reference from our own internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information, and research, surveys, and studies conducted by third parties. Internal estimates are derived from publicly available information released by industry analysts and third-party sources, our internal research, and our industry experience and are based on assumptions made by us based on such data and our knowledge of our industry and market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this Report or any documents incorporated herein by reference is reliable and based on reasonable assumptions, such data involve material risks and other uncertainties and is subject to change based on various factors, including those discussed in the section entitled "Risk Factors." These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us.

**AVAILABLE INFORMATION**

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are filed with the SEC. These reports and other information we file with or furnish to the SEC are available free of charge at https://www.solidpowerbattery.com/investor-relations/financials/sec-filings as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov.

We use our website (www.solidpowerbattery.com) and various social media channels (e.g., Solid Power, Inc. on LinkedIn) as a means of disclosing information about Solid Power and our products to our customers, investors, and the public. The information posted on our website and social media channels is not incorporated by reference in this Report or in any other report or document we file with the SEC. Further, references to our website URLs are intended to be inactive textual references only. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Solid Power when you enroll your e-mail address by visiting the "Investor Email Alerts" section of our website at https://ir.solidpowerbattery.com. Although our executive officers may also use certain social media channels, we do not use our executive officers' social media channels to disclose information about Solid Power or our products.

[**Table of Contents**](#TOC)

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**Solid Power, Inc.**

**Condensed Consolidated Balance Sheets**

**(in thousands, except par value and number of shares)**

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025**<br>**(Unaudited)** | <br>**December 31, 2024** |
| **Assets** |  |  |
| **Current Assets** |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $47286 | $25413 |
| &nbsp;&nbsp;Marketable securities | 203928 | 92784 |
| &nbsp;&nbsp;Contract receivables | 2069 | 1393 |
| &nbsp;&nbsp;Contract assets | 5164 |  |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 3731 | 5646 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 262178 | 125236 |
| **Long-Term Assets** |  |  |
| &nbsp;&nbsp;Property, plant and equipment, net | 88997 | 97208 |
| &nbsp;&nbsp;Right-of-use operating lease assets, net | 6957 | 7490 |
| &nbsp;&nbsp;Investments | 50433 | 210400 |
| &nbsp;&nbsp;Intangible assets, net | 2056 | 2072 |
| &nbsp;&nbsp;Other assets | 1159 | 1577 |
| &nbsp;&nbsp;Loan receivable from equity method investee  | 4364 | 4267 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term assets | 153966 | 323014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**416144** | $**448250** |
| **Liabilities, Mezzanine Equity and Stockholders' Equity** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;Accounts payable and other accrued liabilities  | 9446 | 8409 |
| &nbsp;&nbsp;Deferred revenue | 436 | 3150 |
| &nbsp;&nbsp;Accrued compensation | 5894 | 7578 |
| &nbsp;&nbsp;Operating lease liabilities | 836 | 833 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 16612 | 19970 |
| **Long-Term Liabilities**  |  |  |
| &nbsp;&nbsp;Warrant liabilities | 9537 | 8735 |
| &nbsp;&nbsp;Operating lease liabilities | 7370 | 8023 |
| &nbsp;&nbsp;Other liabilities | 1127 | 1208 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities  | 18034 | 17966 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | **34646** | **37936** |
| **Mezzanine Equity**  |  |  |
| &nbsp;&nbsp;Mezzanine Equity  | **303** | **34** |
| **Stockholders' Equity** |  |  |
| &nbsp;&nbsp;Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 190,209,602 and 180,364,028 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 19 | 18 |
| &nbsp;&nbsp;Additional paid-in capital | 628501 | 591394 |
| &nbsp;&nbsp;Accumulated deficit | (247710) | (181171) |
| &nbsp;&nbsp;Accumulated other comprehensive income | 385 | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total stockholders' equity** | **381195** | **410280** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities, mezzanine equity and stockholders' equity** | $**416144** | $**448250** |

---

**See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).**

[**Table of Contents**](#TOC)

**Solid Power, Inc.**

**Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)**

**(in thousands, except number of shares and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| **Revenues and Grant Income** |  |  |  |  |
| &nbsp;&nbsp;Revenue | $3732 | $4651 | $15342 | $15679 |
| &nbsp;&nbsp;Grant income  | 828 |  | 2774 |  |
| &nbsp;&nbsp;Total revenue and grant income  | 4560 | 4651 | 18116 | 15679 |
| **Operating Expenses** |  |  |  |  |
| &nbsp;&nbsp;Direct costs | 3632 | 6973 | 14790 | 16700 |
| &nbsp;&nbsp;Research and development | 18276 | 17319 | 55639 | 54718 |
| &nbsp;&nbsp;Selling, general and administrative | 7074 | 7950 | 22008 | 24570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 28982 | 32242 | 92437 | 95988 |
| **Operating Loss** | (24422) | (27591) | (74321) | (80309) |
| **Nonoperating Income and Expense** |  |  |  |  |
| &nbsp;&nbsp;Interest income | 3050 | 4251 | 9887 | 13707 |
| &nbsp;&nbsp;Change in fair value of warrant liabilities | (3464) | 1591 | (802) | 1793 |
| &nbsp;&nbsp;Interest expense | (6) | (11) | (21) | (37) |
| &nbsp;&nbsp;Other income (expense) | (58) | (283) | (732) | (167) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total nonoperating income and expense | (478) | 5548 | 8332 | 15296 |
| **Pretax Loss**  | $**(24900)** | $**(22043)** | $**(65989)** | $**(65013)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense  | 360 | 376 | 365 | 887 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share of net loss of equity method investee | 607 |  | 1 |  |
| **Net Loss Attributable to Common Stockholders** | $**(25867)** | $**(22419)** | $**(66355)** | $**(65900)** |
| **Other Comprehensive Income (Loss)** | 161 | 2058 | 346 | 1468 |
| **Comprehensive Loss Attributable to Common Stockholders** | $**(25706)** | $**(20361)** | $**(66009)** | $**(64432)** |
| Basic and diluted loss per share | $(0.14) | $(0.13) | $(0.37) | $(0.37) |
| Weighted average shares outstanding – basic and diluted  | 182350071 | 179160488 | 181369650 | 179177452 |

---

**See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).**

[**Table of Contents**](#TOC)

**Solid Power, Inc.**

**Condensed Consolidated Statement of Stockholders' Equity (Unaudited)**

**(in thousands, except number of shares)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | <br>**Shares** | <br>**Amount** | <br>**Additional**<br>**paid-in capital** | <br>**Accumulated**<br>**deficit** | <br>**Accumulated Other**<br>**Comprehensive Income** | <br>**Total Stockholders'**<br>**Equity** |
| **Balance as of December 31, 2024** | 180364028 | $18 | $591394 | $(181171) | $39 | $410280 |
| Net loss |  |  |  | (15151) |  | (15151) |
| Withholding of employee taxes related to stock-based compensation  |  |  | (261) |  |  | (261) |
| Shares of common stock issued for vested RSUs | 551828 |  |  |  |  |  |
| Stock options exercised | 1532420 |  | 181 |  |  | 181 |
| Stock-based compensation expense |  |  | 1830 |  |  | 1830 |
| Remeasurement of mezzanine equity  |  |  |  | 20 |  | 20 |
| Unrealized gain on available-for-sale securities  |  |  |  |  | 173 | 173 |
| **Balance as of March 31, 2025**  | 182448276 | $18 | $593144 | $(196302) | $212 | $397072 |
| Net loss |  |  |  | (25338) |  | (25338) |
| Shares of common stock issued under the ESPP | 180091 |  | 156 |  |  | 156 |
| Withholding of employee taxes related to stock-based compensation  |  |  | (298) |  |  | (298) |
| Shares of common stock issued for vested RSUs | 1096546 |  |  |  |  |  |
| Stock options exercised | 350757 |  | 478 |  |  | 478 |
| Repurchase and retirement of shares of common stock  | (3361396) |  | (3537) |  |  | (3537) |
| Stock-based compensation expense |  |  | 2153 |  |  | 2153 |
| Remeasurement of mezzanine equity  |  |  |  | (68) |  | (68) |
| Unrealized gain on available-for-sale securities  |  |  |  |  | 13 | 13 |
| **Balance as of June 30, 2025** | 180714274 | $18 | $592096 | $(221708) | $225 | $370631 |
| Net loss |  |  |  | (25867) |  | (25867) |
| Withholding of employee taxes related to stock-based compensation  |  |  | (179) |  |  | (179) |
| Shares of common stock issued for vested RSUs | 377016 |  |  |  |  |  |
| Stock options exercised | 646463 |  | 1207 |  |  | 1207 |
| Stock-based compensation expense |  |  | 2484 |  |  | 2484 |
| Remeasurement of mezzanine equity  |  |  |  | (135) |  | (135) |
| Unrealized gain on available-for-sale securities  |  |  |  |  | 160 | 160 |
| Proceeds from the ATM, net of offering costs, commissions, and fees of $1,201 | 8471849 | 1 | 32893 |  |  | 32894 |
| **Balance as of September 30, 2025** | 190209602 | $19 | $628501 | $(247710) | $385 | $381195 |

---

[**Table of Contents**](#TOC)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | <br>**Shares** | <br>**Amount** | <br>**Additional**<br>**paid-in capital** | <br>**Accumulated**<br>**deficit** | <br>**Accumulated Other**<br>**Comprehensive Loss** | <br>**Total Stockholders'**<br>**Equity** |
| **Balance as of December 31, 2023** | 179010884 | $18 | $588515 | $(84639) | $(559) | $503335 |
| Net loss |  |  |  | (21207) |  | (21207) |
| Withholding of employee taxes related to stock-based compensation  |  |  | (169) |  |  | (169) |
| Shares of common stock issued for vested RSUs | 161995 |  |  |  |  |  |
| Stock options exercised | 2360316 |  | 97 |  |  | 97 |
| Repurchase and retirement of shares of common stock  | (3183638) |  | (4963) |  |  | (4963) |
| Stock-based compensation expense |  |  | 2863 |  |  | 2863 |
| Unrealized loss on available-for-sale securities  |  |  |  |  | (579) | (579) |
| **Balance as of March 31, 2024**  | 178349557 | $18 | $586343 | $(105846) | $(1138) | $479377 |
| Net loss |  |  |  | (22274) |  | (22274) |
| Shares of common stock issued under the ESPP | 187614 |  | 238 |  |  | 238 |
| Withholding of employee taxes related to stock-based compensation  |  |  | (310) |  |  | (310) |
| Shares of common stock issued for vested RSUs | 689221 |  |  |  |  |  |
| Stock options exercised | 1230581 |  | 100 |  |  | 100 |
| Repurchase and retirement of shares of common stock  | (1816362) |  | (3393) |  |  | (3393) |
| Stock-based compensation expense |  |  | 3051 |  |  | 3051 |
| Unrealized loss on available-for-sale securities  |  |  |  |  | (11) | (11) |
| **Balance as of June 30, 2024** | 178640611 | $18 | $586029 | $(128120) | $(1149) | $456778 |
| Net loss |  |  |  | (22419) |  | (22419) |
| Withholding of employee taxes related to stock-based compensation  |  |  | (75) |  |  | (75) |
| Shares of common stock issued for vested RSUs | 160842 |  |  |  |  |  |
| Stock options exercised | 832122 |  | 35 |  |  | 35 |
| Stock-based compensation expense |  |  | 3073 |  |  | 3073 |
| Unrealized loss on available-for-sale securities  |  |  |  |  | 2058 | 2058 |
| **Balance as of September 30, 2024** | 179633575 | $18 | $589062 | $(150539) | $909 | $439450 |

---

**See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).**

[**Table of Contents**](#TOC)

**Solid Power, Inc.**

**Condensed Consolidated Statements of Cash Flows (Unaudited)**

**(in thousands)**

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** |
| **Cash Flows from Operating Activities** |  |  |
| &nbsp;&nbsp;Net loss | $(66355) | $(65900) |
| &nbsp;&nbsp;Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 13770 | 11991 |
| &nbsp;&nbsp;Amortization of right-of-use assets | 1071 | 642 |
| &nbsp;&nbsp;Loss on sales of property, plant and equipment, net | 574 |  |
| &nbsp;&nbsp;Share of net loss of equity method investee  | 1 |  |
| &nbsp;&nbsp;Stock-based compensation expense | 6467 | 8987 |
| &nbsp;&nbsp;Change in fair value of warrant liabilities | 802 | (1793) |
| &nbsp;&nbsp;Accretion of discounts on other long-term liabilities | 49 | 52 |
| &nbsp;&nbsp;Accretion of loan receivable from equity method investee | (97) |  |
| &nbsp;&nbsp;Amortization of premiums and accretion of discounts on available-for-sale securities  | (3579) | (6260) |
| &nbsp;&nbsp;Loss on change in assessment of finance lease purchase options | 84 |  |
| &nbsp;&nbsp;Impairment loss on abandoned patents | 748 |  |
| &nbsp;&nbsp;Change in operating assets and liabilities that provided (used) cash and cash equivalents: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract receivables and contract assets | (5597) | (1061) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets and other assets | 2360 | 707 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other accrued liabilities | (121) | (664) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (2714) | 6734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue from related parties  |  | (828) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | (1684) | (2027) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (781) | (610) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash and cash equivalents used in operating activities | (55002) | (50030) |
| **Cash Flows from Investing Activities** |  |  |
| &nbsp;&nbsp;Purchases of property, plant and equipment, net | (5614) | (11236) |
| &nbsp;&nbsp;Purchases of available-for-sale securities  | (158770) | (174040) |
| &nbsp;&nbsp;Proceeds from sales of available-for-sale securities  | 211085 | 252177 |
| &nbsp;&nbsp;Cash paid for loan receivable from equity method investee |  | (4448) |
| &nbsp;&nbsp;Purchases of intangible assets | (602) | (314) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash and cash equivalents provided by investing activities | 46099 | 62139 |
| **Cash Flows from Financing Activities** |  |  |
| &nbsp;&nbsp;Proceeds from exercise of stock options | 1866 | 232 |
| &nbsp;&nbsp;Proceeds from issuance of shares of common stock under the ESPP | 156 | 238 |
| &nbsp;&nbsp;Cash paid for withholding of employee taxes related to stock-based compensation  | (736) | (554) |
| &nbsp;&nbsp;Repurchase of shares of common stock  | (3592) | (8274) |
| &nbsp;&nbsp;Payments on finance lease liabilities | (232) | (319) |
| &nbsp;&nbsp;Proceeds from the ATM, net of commissions and fees | 33412 |  |
| &nbsp;&nbsp;Offering costs for the issuance of common stock under the ATM | (98) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash and cash equivalents provided by (used in) financing activities | 30776 | (8677) |
| Net increase in cash and cash equivalents | 21873 | 3432 |
| Cash and cash equivalents at beginning of period | 25413 | 34537 |
| Cash and cash equivalents at end of period | 47286 | 37969 |
| **Supplemental information** |  |  |
| Cash paid for interest | $21 | $37 |
| Accrued capital expenditures | 1933 | 2041 |
| Accrued intangibles | 155 |  |
| Unpaid reimbursements on capital expenditures | 242 |  |
| Accrued offering costs for the issuance of common stock under the ATM | 421 |  |
| Accrued excise tax on stock repurchases | 35 | 82 |

---

**See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).**

[**Table of Contents**](#TOC)

#### Notes to Condensed Consolidated Financial Statements (Unaudited) (in thousands, except number of shares and per share amounts)

#### Note 1 – Nature of Business
Solid Power, Inc. (the "Company") is developing solid-state battery technology for the battery electric vehicle ("EV") and other markets. The Company's planned business model is to sell its electrolyte and to license its cell designs and manufacturing processes.

#### Note 2 – Significant Accounting Policies
The significant accounting policies followed by the Company are set forth in Note 2 – Significant Accounting Policies to the Company's financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K") and are supplemented by the Notes to the Condensed Consolidated Financial Statements (Unaudited) in this Report (the "Notes"). The financial statements included in this Quarterly Report on Form 10-Q (including the Notes) should be read in conjunction with the 2024 Form 10-K.

***Basis of Presentation and Principles of Consolidation***

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on the basis of U.S. generally accepted accounting principles ("GAAP") and reflect all adjustments of a normal recurring nature, which are, in the opinion of management, necessary for a fair presentation of the consolidated financial position and results of operations at, and for, the periods presented. The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from those estimates. All dollar amounts presented herein are in U.S. dollars and are in thousands, except par value and share and per share amounts. The accompanying unaudited condensed consolidated financial statements include accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company accounts for its equity ownership in Dahae Energy Co., Ltd. ("Dahae"), an entity in which the Company does not exercise control or have the obligation to absorb losses or receive benefits, as a variable interest entity ("VIE"). A VIE is a legal entity that possess any of the following conditions: the entity's equity at risk is not sufficient to permit the legal entity to finance its activities without additional subordinated financial support, equity owners are unable to direct the activities that most significantly impact the legal entity's economic performance (or they possess disproportionate voting rights in relation to the economic interest in the legal entity), or the equity owners lack the obligation to absorb the legal entity's expected losses or the right to receive the legal entity's expected residual returns. The Company consolidates a VIE if the Company determines that it has (i) the power to direct the activities of the VIE that most significantly impacts its economic performance and (ii) the obligation to absorb losses or the right to receive benefits from the VIE that are more than insignificant to the VIE. If an entity is determined to be a VIE but the Company does not have a controlling interest, the entity is accounted for under either the cost or equity method depending on whether the Company exercise significant influence. The Company has determined that it does not meet the control requirements to consolidate Dahae and accounts for the investment using the equity method of accounting. The Company evaluates its relationships with Dahae on an ongoing basis, including when the Company believes a loss in value may have occurred which is other than temporary. The Company measures its equity method investment at cost minus impairment, if any, plus or minus the share of the equity method investee's loss or gain. Activity is included in Investments in the Condensed Consolidated Balance Sheets and separately within Share of net loss of equity method investee in the Condensed Consolidated Statements of Operations and Comprehensive Loss and within Cash Flows from Investing Activities in the Condensed Consolidated Statements of Cash Flows.

***Available-for-Sale Securities***

The Company considers all available-for-sale securities with a maturity date of less than 12 months to be marketable securities and all with a maturity date greater than 12 months to be investments. See Note 6 – Fair Value Measurement for more information.

***Revenue and Grant Income***

The Company assesses all collaborative arrangements to determine whether the agreement should be recorded in accordance with Accounting Standards Codification ("ASC") 808 – Collaborative Arrangements. Collaborative arrangements involve two or more parties who are active participants and meet the following components: both parties are exposed to significant risks and rewards, and both parties are dependent on the commercial success of the efforts under the contract. Revenue recognition is recorded by analogy to

[**Table of Contents**](#TOC)

ASC 606 – Revenue from Contracts with Customers. The Company's agreements with SK On Co., Ltd. ("SK On" and such agreements, the "SK On Agreements") meet the criteria of collaborative arrangements. Amounts received for these products and services are classified as Revenue in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Prior to January 1, 2025, the Company recognized revenue from the Company's collaborative arrangement, including the SK On Agreements, over time using the input measurement method utilizing labor hours in relation to total labor hours anticipated to satisfy the performance obligation. Effective January 1, 2025 the Company changed its basis of input to utilize the cost-to cost method to satisfy the performance obligation. The Company made this adjustment because it believes using the cost-to-cost method provides more accurate reflection of how performance is satisfied over time. This adjustment is treated as a change in estimate beginning on January 1, 2025, and prior period amounts will not be adjusted. The Company expenses contract fulfillment costs as incurred.

The Company estimates whether it will be subject to variable consideration under the terms of a contract and includes its estimate of variable consideration, subject to constraint, in the transaction price based on the expected value method when it is deemed probable of being realized based on historical experience and trends. The Company updates its estimate of the transaction price each reporting period, and the effect of variable consideration on the transaction price is recognized as an adjustment to revenue on a cumulative catch-up basis.

The Company recognizes revenue from cooperative agreements with the government in cost contracts on the basis of costs incurred during the period and for cost plus fixed-fee contracts on the basis of costs incurred during the period plus the fee earned. Contract costs include all direct labor, subcontract, material, and indirect costs related to the contract performance.

On January 21, 2025, Solid Power Operating, Inc. entered into an assistance agreement with the U.S. Department of Energy ("DOE") with an effective date of January 1, 2025 (as amended effective May 15, 2025, the "Assistance Agreement"). The Assistance Agreement provides that DOE will provide the Company with funding of up to $50,000 for the Company's installation of equipment necessary for the continuous production of sulfide-based electrolyte material pilot line. The Company records grant income from the Assistance Agreement in accordance with International Accounting Standards 20 when conditions have been substantially met. This income is presented within Grant income in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

For electrolyte sales, the Company recognizes revenue when the control of the goods is transferred to the customer and for the amount of consideration the Company expects to receive.

***Reclassification of Prior Year Presentation***

Certain prior period amounts have been reclassified to conform to current period presentation in the accompanying unaudited condensed consolidated financial statements. Beginning in January 2025, reclassifications have been made to prior year amounts within the Condensed Consolidated Balance Sheets in which balances have been moved from Right-of-use financing lease assets to Other Assets; Finance lease liabilities, short-term to Accounts payable; and other accrued liabilities, and Finance lease liabilities, long-term to Other liabilities. These changes had no effect on the reported results of operations.

***Segment Reporting***

The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment as the CODM reviews financial information presented as a single entity for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM manages the business on a consolidated basis and uses consolidated Net Loss Attributable to Common Stockholders as reported in the Condensed Consolidated Statements of Operations and Comprehensive Loss as the profit or loss measure in assessing performance and deciding how to allocate resources. The CODM is regularly provided with only the consolidated expenses as classified and presented in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

***Recent Accounting Pronouncements***

In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-09 *Income Taxes* (Topic 740) Improvements to Income Tax Disclosures. ASU 2023-09 requires companies to disclose, on an annual basis, specific categories in the effective tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. In addition, ASU 2023-09 requires companies to disclose additional information about income taxes paid. ASU 2023-09 will be effective for annual periods beginning January 1, 2025 and will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is evaluating the impact.

[**Table of Contents**](#TOC)

In November 2024, the FASB issued ASU No. 2024-03 Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses. ASU 2024-03 requires disclosure of specified information about certain costs and expenses in the notes to the financial statements. ASU 2024-03 will be effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. ASU 2024-03 can be applied either prospectively to financial statements or retrospectively to any prior periods presented in the financial statements. The Company is evaluating the impact.

In July 2025, the FASB, issued ASU No. 2025-05 Financial Instruments – Credit Losses (Topic 326). ASU 2025-05 clarifies guidance related to Topic 326 for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers, and allowing for a practical expedient that assumes that current conditions as of the balance sheet do not change for the remaining life of the asset. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is evaluating the impact.

#### Note 3 – Property, Plant and Equipment, Net
Property, plant and equipment, net are summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Production equipment | $43704 | $41750 |
| Laboratory equipment  | 14625 | 12611 |
| Leasehold improvements  | 73258 | 73114 |
| Furniture and computer equipment  | 4478 | 4298 |
| Construction in progress  | 6392 | 5141 |
| &nbsp;&nbsp;Total cost  | 142457 | 136914 |
| Accumulated depreciation  | (53460) | (39706) |
| &nbsp;&nbsp;Property, plant and equipment, net | $88997 | $97208 |

---

Depreciation expenses for dedicated laboratory equipment and production equipment are charged to research and development. Office equipment, leasehold improvements, software, and computer equipment related depreciation expenses are allocated between research and development and selling, general and administrative expenses based on the nature of its use.

Depreciation expense related to property, plant and equipment are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Depreciation expense | $4623 | $4014 | $13754 | $11980 |

---

As of September 30, 2025, the Company is designing a continuous electrolyte production pilot line which it expects to be substantially complete and commissioned by the end of 2026. Additionally, the Company has built out the majority of the cell safety abuse lab to expand internal cell testing capabilities and is enhancing the capabilities of the electrolyte innovation center (the "EIC"). Construction in progress related to property, plant and equipment is summarized as follows:

---

| | | |
|:---|:---|:---|
| Construction in progress | **September 30, 2025** | **December 31, 2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuous electrolyte pilot manufacturing line | $4252 | $1194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cell safety abuse lab | 6 | 835 |
| &nbsp;&nbsp;&nbsp;&nbsp;EIC | 344 | 1292 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other capital projects | 1790 | 1820 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total  | $6392 | $5141 |

---

[**Table of Contents**](#TOC)

#### Note 4 – Intangible Assets
Intangible assets are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Gross Carrying**<br>**Amount** | **Accumulated**<br>**Amortization** | **Gross Carrying**<br>**Amount** | **Accumulated**<br>**Amortization** |
| Intangible assets: |  |  |  |  |
| &nbsp;&nbsp;Licenses | $149 | $(76) | $149 | $(69) |
| &nbsp;&nbsp;Patents | 259 | (22) | 135 | (12) |
| &nbsp;&nbsp;Patents pending | 1699 |  | 1831 |  |
| &nbsp;&nbsp;Trademarks | 13 |  | 13 |  |
| &nbsp;&nbsp;Trademarks pending  | 34 |  | 25 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total amortizable intangible assets | $2154 | $(98) | $2153 | $(81) |

---

[**Table of Contents**](#TOC)

Amortization expense for intangible assets is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Amortization expense | $5 | $4 | $16 | $11 |

---

Useful lives of intangible assets range from three to 20 years. Amortization expenses are expensed within research and development expense within Operating Expenses in the Company's Condensed Consolidated Statements of Operations and Comprehensive Loss.

During the third quarter of 2025, the Company concluded there were assets on the Condensed Consolidated Balance Sheets related to patent application costs for the patents that the Company is no longer pursuing. As the carrying amount of the intangible asset was not recoverable and the carrying value exceeded its fair value, an impairment loss was recognized. As of September 30, 2025, the Company recognized $748 in impairment loss which is presented in research and development expense within the Condensed Consolidated Statements of Operations and Comprehensive Loss.

#### Note 5 – Revenue and Grant Income
The Company receives revenue and grant income from both government and non-government entities. Government revenue and grant income includes both revenue and grant income from collaborative arrangements. Non-government revenue includes both revenue from collaborative arrangements and electrolyte sales. The table below sets forth revenue and grant income by type for the three and nine months ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Government - revenue | $762 | $1100 | $1930 | $2392 |
| Government - grant income | 828 | - | 2774 | - |
| Non-government revenue | 2970 | 3551 | 13412 | 13287 |
| Total revenue and grant income  | $4560 | $4651 | $18116 | $15679 |

---

#### Note 6 – Fair Value Measurements
The carrying amount of certain financial instruments, such as cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value due to their relatively short maturities. The difference between the amortized cost and fair value of available-for-sale securities as of September 30, 2025 and December 31, 2024 was not material.

#### Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
The following table summarizes the asset type, balance sheet classification, maturity, and value of the Company's marketable securities and investments in the Condensed Consolidated Balance Sheets.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Assets** | **Balance Sheet Classification**  | **Maturity**  | **September 30, 2025** | **December 31, 2024** |
| Commercial Paper | Marketable securities | Due in 1 year or less  | $51680 | $47046 |
| Corporate Bonds | Marketable securities | Due in 1 year or less  | 122409 | 28614 |
| Government Bonds | Marketable securities | Due in 1 year or less  | 25864 |  |
| U.S. Treasuries | Marketable securities | Due in 1 year or less  | 3975 | 17124 |
|  | Total Marketable securities  |  | $203928 | $92784 |
| Corporate Bonds | Investments | Due in 1 year to 5 years  | $28359 | $173369 |
| Government Bonds | Investments | Due in 1 year to 5 years  | 20854 | 35904 |
| Equity Method Investment | Investments |  | 1220 | 1127 |
|  | Total Investments |  | $50433 | $210400 |

---

[**Table of Contents**](#TOC)

See Note 2 – Significant Accounting Policies to the Company's financial statements included in the 2024 Form 10-K, as supplemented by the Notes, for information regarding Levels 1 through Level 3 inputs.

As of September 30, 2025 and December 31, 2024, the Company's financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|  |  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | **Balance Sheet Classification**  |  |  |  |  |
| Commercial Paper | Marketable securities | $51680 | $— | $— | $51680 |
| Corporate Bonds | Marketable securities | $122409 | $— | $— | $122409 |
| Government Bonds | Marketable securities | $25864 | $— | $— | $25864 |
| U.S. Treasuries | Marketable securities | $3975 | $— | $— | $3975 |
| Corporate Bonds | Investments | $28359 | $— | $— | $28359 |
| Government Bonds | Investments  | $20854 | $— | $— | $20854 |
| Bifurcated embedded derivative  | Loan receivable from equity method investee | $— | $— | $584 | $584 |
| **Liabilities** |  |  |  |  |  |
| Public Warrants | Warrant liabilities  | $5683 | $— | $— | $5683 |
| Private Placement Warrants | Warrant liabilities  | $— | $3854 | $— | $3854 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  |  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | **Balance Sheet Classification**  |  |  |  |  |
| Commercial Paper | Marketable securities | $47046 | $— | $— | $47046 |
| Corporate Bonds | Marketable securities | $28614 | $— | $— | $28614 |
| U.S. Treasuries | Marketable securities | $17124 | $— | $— | $17124 |
| Corporate Bonds | Investments | $173369 | $— | $— | $173369 |
| Government Bonds | Investments | $35904 | $— | $— | $35904 |
| Bifurcated embedded derivative  | Loan receivable from equity method investee | $— | $— | $584 | $584 |
| **Liabilities** |  |  |  |  |  |
| Public Warrants | Warrant liabilities | $5537 | $— | $— | $5537 |
| Private Placement Warrants | Warrant liabilities  | $— | $3198 | $— | $3198 |

---

The change in fair value of the Company's marketable securities and investments are included in Other Comprehensive Income (Loss) in the Company's Condensed Consolidated Statements of Operations and Comprehensive Loss. There were no transfers in and out of Level 3 fair value hierarchy during the three and nine months ended September 30, 2025 or year ended December 31, 2024. During the nine months ended September 30, 2025 and 2024, the Company purchased $158,770 and $174,040 of available-for-sale securities, respectively.

*Fair Value of Bifurcated Embedded Derivative* 

The fair value of the bifurcated embedded derivative (the "Derivative") has been estimated using the with-and-without method as of September 30, 2025 using Level 3 unobservable inputs and Level 2 directly or indirectly observable inputs, including estimated credit rating, risk-free interest rates, and expected future cash flows. Material increases or decreases in any of those inputs may result in a significantly higher or lower fair value measurement. Material increases or decreases in expected future cash flows may result in a significantly higher or lower estimated fair value of the Derivative. See Note 12 – Related Party Transactions for more information.

*Fair Value of Warrants* 

The fair value of the private placement warrants issued as part of the Company's business combination in 2021 (the "Private Placement Warrants") have been estimated using a Black-Scholes model as of September 30, 2025 and December 31, 2024. The

[**Table of Contents**](#TOC)

estimated fair value of the Private Placement Warrants is determined using Level 2 directly or indirectly observable inputs. Inherent in a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, and dividend yield. Material increases (or decreases) in any of those inputs may result in a significantly higher (or lower) fair value measurement. The Company estimates the volatility of its Private Placement Warrants based on implied volatility from the Company's publicly-traded warrants (the "Public Warrants" and, together with the Private Placement Warrants, the "Warrants") and from historical volatility of select peer companies' common stock that matches the expected remaining life of the Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Warrants. The dividend yield is based on the historical rate, which the Company anticipates remaining at zero. The fair value of the Public Warrants has been measured based on the quoted price of such warrants on the Nasdaq Stock Market, a Level 1 input.

The following table provides quantitative information regarding Level 2 inputs used in the recurring valuation of the Private Placement Warrants as of their measurement dates.

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Exercise price | $11.50 | $11.50 |
| Stock price | $3.47 | $1.89 |
| Volatility | 112.4% | 124.8% |
| Term (in years) | 1.19 | 1.94 |
| Risk-free rate | 3.60% | 4.16% |

---

The following table provides a rollforward (per Warrant) of the Public Warrants measured at fair value using Level 1 inputs and Private Placement Warrants measured at fair value using Level 2 inputs.

---

| | | |
|:---|:---|:---|
|  | **Public Warrants**<br>**Level 1 Fair Value** | **Private Placement Warrants**<br>**Level 2 Fair Value** |
| December 31, 2024 | $0.42 | $0.52 |
| Change in fair value | $(0.25) | $(0.42) |
| March 31, 2025 | $0.17 | $0.10 |
| Change in fair value | $0.16 | $0.18 |
| June 30, 2025 | $0.33 | $0.28 |
| Change in fair value | $0.10 | $0.35 |
| September 30, 2025 | $0.43 | $0.63 |

---

See Note 7 – Warrant Liabilities for more information.

#### Note 7 – Warrant Liabilities
The table below provides a summary of the outstanding Public and Private Placement Warrants.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | **September 30, 2025** |  | **December 31, 2024** |
| Public Warrants  |  | 13,215,758 |  | 13,182,501 |
| Private Placement Warrants  |  | 6,117,545 |  | 6,150,802 |

---

Each whole Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to customary adjustments. Only whole Warrants are exercisable. The Warrants became exercisable on January 7, 2022 and will expire on December 8, 2026.

None of the Private Placement Warrants are redeemable by the Company so long as they are held by the initial purchasers of the Private Placement Warrants or their permitted transferees. The table below provides the fair value of warrant liabilities at:

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Fair value of warrant liabilities | $9537 | $8735 |

---

[**Table of Contents**](#TOC)

The table below provides the gain (loss) recognized in connection with changes in fair value of warrant liabilities at:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Gain (Loss) recognized associated with warrant liabilities  | $(3464) | $1591 | $(802) | $1793 |

---

There have been no changes to the terms of the Public or Private Placement Warrants disclosed in the 2024 Form 10-K.

#### Note 8 – Stockholders' Equity
***Common Stock***

Stock options exercised for common stock, shares of common stock issued under the Solid Power, Inc. 2021 Employee Stock Purchase Plan (the "ESPP"), shares of common stock issued upon vesting of restricted stock units ("RSUs"), and shares of common stock repurchased under the stock repurchase program for the three and nine months ended September 30, 2025 and 2024 are summarized in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Stock options exercised | 646463 | 832122 | 2529640 | 4423019 |
| Shares of common stock issued under the ESPP |  |  | 180091 | 187614 |
| Shares of common stock issued for vested RSUs | 377016 | 160842 | 2025390 | 1012058 |
| Shares of common stock issued under the ATM | 8471849 |  | 8471849 |  |
| Shares of common stock repurchased  |  |  | (3361396) | (5000000) |

---

The table below presents the cash received or paid associated with common stock related activities for the three and nine months ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Cash received from stock options exercised | $1207 | $35 | $1866 | $232 |
| Cash received from shares of common stock issued under the ESPP |  |  | 156 | 238 |
| Cash received from shares of common stock issued under the ATM  | 33412 |  | 33412 |  |
| Cash paid for shares of common stock repurchased |  |  | (3592) | (8274) |

---

***At-the-Market Offering***

On September 5, 2025, the Company entered into an Equity Distribution Agreement (the "Distribution Agreement") with Oppenheimer & Co. Inc., serving as agent ("Oppenheimer"), with respect to an at-the-market offering program (the "ATM") under which the Company may offer and sell, from time to time, shares of its common stock having an aggregate offering price of up to $150,000 through Oppenheimer. During the three months ended September 30, 2025, the Company sold 8,471,849 shares of common stock at an average price of $4.02 per share under the Distribution Agreement, raising gross proceeds of $34,094 before deducting offering costs, commissions, and fees. Net proceeds to the Company totaled $32,894 after deducting offering costs, commissions, and fees. As of September 30, 2025 approximately $115,906 remained available for future sales under the Distribution Agreement.

[**Table of Contents**](#TOC)

***Stock Repurchase Program***

On January 23, 2024, the Company announced that its Board of Directors approved a stock repurchase program ("Program") authorizing the Company to purchase up to $50,000 of the Company's outstanding common stock. Under the Program, the Company may purchase shares of its common stock from time to time until the Program expires on December 31, 2025. As of September 30, 2025, the approximate dollar value of shares that may yet be purchased under the Program is $37,335.

The table below presents the number of shares repurchased and retired, the principal, commissions, and total cash paid to repurchase and retire shares of common stock, the excise tax, and the average purchase price per share for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Repurchased and retired shares of common stock |  |  | 3361396 | 5000000 |
| Principal paid to repurchase and retire shares of common stock |  |  | 3525 | 8174 |
| Commissions paid to repurchase and retire shares of common stock |  |  | 67 | 100 |
| Total cash paid to repurchase and retire shares of common stock  |  |  | (3592) | (8274) |
| Excise tax accrued  |  |  | 35 | 82 |
| Average price paid per share (including commissions) | $— | $— | $1.07 | $1.65 |

---

#### Note 9 – Stock-Based Compensation
There have been no changes to the Solid Power, Inc. 2014 Equity Incentive Plan (the "2014 Plan"), the Solid Power, Inc. 2021 Equity Incentive Plan (the "2021 Plan"), the Solid Power, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), the Company's accounting for stock-based compensation under those plans, or the restricted stock grants to two Dahae executives, as disclosed in the 2024 Form 10-K.

The fair value of stock options and RSUs under the 2021 Plan is recognized as compensation expense over the vesting period of the award. The Company accounts for forfeitures as they occur.

For the three and nine months ended September 30, 2025 and 2024, the Company recognized compensation costs totaling:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Stock-based compensation costs related to RSUs | $1845 | $1499 | $4333 | $4107 |
| Stock-based compensation costs related to stock options | 560 | 1529 | 1917 | 4756 |
| Stock-based compensation costs related to the ESPP | 78 | 45 | 217 | 124 |
| Total stock-based compensation costs | $2483 | $3073 | $6467 | $8987 |

---

Unrecognized future compensation costs as of September 30, 2025 were $20,051. The Company expects to recognize the future compensation cost over a weighted-average period of 2.8 years, amortized over a straight-line basis.

[**Table of Contents**](#TOC)

The following table summarizes the Company's award activity for RSUs and stock options for the three and nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **RSUs** | **Stock Options** |
| Balance at December 31, 2024 | 8200553 | 20605693 |
| Granted | 882741 |  |
| Vested or Exercised  | (744956) | (1532420) |
| Forfeited  | (901711) | (1788613) |
| Balance at March 31, 2025  | 7436627 | 17284660 |
| Granted | 7911546 |  |
| Vested or Exercised  | (1287036) | (350757) |
| Forfeited  | (498302) | (2371676) |
| Balance at June 30, 2025 | 13562835 | 14562227 |
| Granted | 395304 |  |
| Vested or Exercised  | (460092) | (646463) |
| Forfeited  | (510535) | (786168) |
| Balance at September 30, 2025 | 12987512 | 13129596 |

---

***Stock Options***

For the nine months ended September 30, 2025, no stock options were granted. The fair value of each stock option grant during the nine months ended September 30, 2024 was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions used:

---

| | |
|:---|:---|
|  | **Nine Months Ended September 30,**  |
|  | **2024** |
| Approximate risk-free rate | 4.23% |
| Volatility | 48.1% |
| Average expected life (in years) | 6 |
| Dividend yield | —% |
| Weighted-average grant date fair value | $1.59 |
| Estimated fair value of total stock options granted | $5175 |

---

***Restricted Stock Grants to Dahae Executives***

On October 21, 2024, the Company issued 298,508 shares of restricted stock to two executive employees of Dahae pursuant to the provisions of Regulation S under the Securities Act of 1933, as amended. This issuance was not under any existing plan. The restricted stock vests over a four-year period, subject to forfeiture upon the applicable stockholder ceasing to provide services to Dahae or upon Dahae's default on the financing instruments entered into between the Company and Dahae on October 21, 2024. As of September 30, 2025, 87,319 shares vested. Stock-based compensation expense is recognized within Share of net loss of equity method investee in the Condensed Consolidated Statements of Operations and Comprehensive Loss. No additional shares of restricted stock are authorized for issuance to Dahae executives.

[**Table of Contents**](#TOC)

#### Note 10 – Basic and Diluted Loss Per Share
The table below sets forth the basic and diluted loss per share calculation for the three and nine months ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Net loss attributable to common stockholders | $(25867) | $(22419) | $(66355) | $(65900) |
| Weighted average shares outstanding – basic and diluted  | 182350071 | 179160488 | 181369650 | 179177452 |
| Basic and diluted loss per share | $(0.14) | $(0.13) | $(0.37) | $(0.37) |

---

Due to the net loss for the three and nine months ended September 30, 2025 and 2024, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. The table below sets forth (in shares) potentially dilutive securities excluded from the diluted loss per share calculation.

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** |
| Warrants | 19333303 | 19333303 |
| 2014 Plan & 2021 Plan - Stock Options | 15504480 | 23497907 |
| 2021 Plan - RSUs | 10487772 | 6764178 |
| ESPP - Common Stock  | 160732 | 167548 |
| Restricted stock grants to Dahae executives | 143461 |  |
| &nbsp;&nbsp;Total potentially dilutive securities | 45629748 | 49762936 |

---

#### Note 11 – Leases
The Company leases its facilities and certain equipment. Fixed rent for the Company's facilities escalates each year, and the Company is responsible for a portion of the landlords' operating expenses such as property tax, insurance, and common area maintenance.

The Company's facility in Louisville, Colorado is under a noncancelable operating lease with a maturity date in December 2029. In 2022, the Company amended this operating lease to incorporate a prior subleased space into the base lease and extend the term of the lease. In 2024, the Company amended this operating lease to incorporate additional space and further extend the term of the lease. The Company has the right to renew this operating lease for an additional five-year period.

On September 1, 2021, the Company entered into an industrial operating lease agreement for its facility in Thornton, Colorado, with the initial term through March 31, 2029. Under this operating lease, the Company has one option to renew for five years, which has been included in the calculation of lease liabilities and right-of-use assets as the exercise of the option is reasonably certain. As the renewal rent has not been negotiated, the Company used an estimated rent rate which approximated the fair market rent at adoption of ASC 842 on January 1, 2022 for the extension period.

The Company has certain equipment leases classified as finance leases as of September 30, 2025. In the Condensed Consolidated Balance Sheets, the Company records its right-of-use finance lease assets, net within Other assets, records its short-term finance lease liabilities within Accounts payable and other accrued liabilities, and records its long-term finance lease liabilities within Other liabilities.

The Company's leases do not have any contingent rent payments and do not contain residual value guarantees.

[**Table of Contents**](#TOC)

The components of lease expense are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Finance lease costs: |  |  |  |  |
| &nbsp;&nbsp;Amortization of right-of-use assets | $104 | $58 | $407 | $174 |
| &nbsp;&nbsp;Interest on lease liabilities | 6 | 11 | 21 | 37 |
| Operating lease costs | 376 | 302 | 1129 | 883 |
| Total lease expense | $486 | $371 | $1557 | $1094 |

---

The components of cash flow information related to leases are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Operating outgoing cash flows – finance leases | $6 | $11 | $21 | $38 |
| Financing outgoing cash flows – finance leases | 62 | 95 | 228 | 281 |
| Operating outgoing cash flows – operating leases | 338 | 441 | 1008 | 1025 |
| Right-of-use assets obtained in exchange for new, modified, and remeasured finance lease liabilities: |  |  | (1) |  |
| Right-of-use assets obtained in exchange for new, modified, and remeasured operating lease liabilities: |  | 148 | 15 | 148 |

---

The supplemental balance sheet information related to leases are as follows:

---

| | |
|:---|:---|
|  | **September 30, 2025** |
| **Finance lease** |  |
| Weighted-average remaining lease term – finance leases (in years) | 1.9 |
| Weighted-average discount rate – finance leases | 6.9% |
| **Operating lease** |  |
| Weighted-average remaining lease term – operating leases (in years) | 7.3 |
| Weighted-average discount rate – operating leases | 6.3% |

---

As of September 30, 2025, future minimum payments during the next five years and thereafter are as follows:

---

| | | |
|:---|:---|:---|
| Fiscal year | **Finance Lease** | **Operating Lease** |
| 2025 (remaining three months) | 57 | 344 |
| 2026 | 179 | 1403 |
| 2027 | 85 | 1448 |
| 2028 | 16 | 1494 |
| 2029 |  | 1548 |
| 2030 |  | 903 |
| Thereafter |  | 3127 |
| Total | 337 | 10267 |
| Less present value discount | (19) | (2061) |
| Total lease liabilities | $318 | $8206 |

---

#### Note 12 – Related Party Transactions

#### BMW of North America LLC
During 2022, the Company amended its joint development agreement ("JDA") with BMW of North America LLC ("BMW") to provide a research and development-only license to certain of the Company's intellectual property relating to cell manufacturing. The license allows, among other things, BMW to install a solid-state prototype cell manufacturing line based on the Company's

[**Table of Contents**](#TOC)

proprietary information. The license is limited to BMW's research and development activities and may not be used for commercial battery cell production. During 2024, the Company further amended its JDA with BMW to extend the term of the JDA, revise the payment schedule, and revise certain deliverables and the timing to achieve various milestone and development targets and confirm cell performance requirements.

Before BMW's installation of its cell manufacturing line, the Company and BMW have agreed to joint development and manufacturing activities at the Company's facilities. Any intellectual property developed jointly by the Company and BMW at the Company's facilities will be solely owned by the Company. To the extent intellectual property is jointly conceived elsewhere, the Company and BMW will jointly own such intellectual property. The intellectual property developed by us or BMW individually will be owned by such party. Both parties will have the right to utilize the other party's technical improvements for research and development purposes only. The Company, with certain limitations, has the right to cause BMW to license BMW's technical improvements to the Company for commercial purposes.

BMW agreed to pay the Company $20,000 between December 2022 and June 2025, subject to the Company achieving certain milestones. During the three and nine months ended September 30, 2025, the Company recognized $0 of revenue related to its JDA. In addition, the Company recognized $39 and $171 of revenue for the three and nine months ended September 30, 2025 respectively, from the sale of cell materials to BMW. During the three and nine months ended September 30, 2024, the Company recognized $0 and $5,410 of revenue related to its JDA, respectively.

#### Dahae Energy Co., Ltd.
During 2024, the Company entered into a series of transactions with Dahae, a strategic partner in the Republic of Korea. Dahae provides process engineering support for the Company's pilot cell lines and is serving as the installer for installation of a pilot cell manufacturing line at SK On's facility. The transactions included, among other things, a bond (the "Bond") with detachable warrants (the "Detachable Warrants") and the Derivative, restricted stock grants to two Dahae executives, and a term loan facility. During the three and nine months ended September 30, 2025, the Company incurred $2,100 and $10,204 of cost related to services provided by Dahae, respectively.

The Company acquired a 20% equity interest in Dahae for $656 (including $256 of transaction costs) and recorded the investment using the equity method of accounting.

As of September 30, 2025 and December 31, 2024, the Bond had an unamortized discount of $1,830 and $1,927, respectively.

The Company recorded the Detachable Warrants within Investments in the Condensed Consolidated Balance Sheets at a fair value upon acquisition of $607. The Detachable Warrants are fully detachable from the Bond and can be exercised for shares of Dahae's common stock. If the Company were to exercise the Detachable Warrants in full, the Company would own 40% of the then outstanding shares of common stock of Dahae. As of September 30, 2025 and December 31, 2024, there were no impairments or downward or upward adjustments to Detachable Warrants since acquisition.

The Company granted 298,508 shares of restricted stock grants to two Dahae executives, of which as of September 30, 2025, 87,319 shares vested. The restricted stock grants are subject to redemption at fair value once all shares are fully vested and any financing provided by the Company to Dahae has been repaid. As the restricted stock grants are contingently redeemable at fair value, the restricted stock grants are recorded within Mezzanine Equity in the Condensed Consolidated Balance Sheets. To adjust these grants to redemption amounts at each reporting period, the Company remeasures the grants to their redemption value based on the price of the Company's common stock, with a corresponding entry to the Company's retained earnings. The remeasurement for the nine months ended September 30, 2025 and year ended December 31, 2024 was $134 and $12, respectively.

The Company entered into a term loan facility with Dahae. Dahae drew upon the facility on November 3, 2024, with a principal balance of $1,161 issued at par, explicit interest rate of 3%, and maturity date of October 21, 2034. The loan is recorded within Loan receivable from equity method investee in the Condensed Consolidated Balance Sheets.

All financing agreements between the Company and Dahae are collateralized by Dahae's assets and a minority equity interest in Dahae. The Company has committed to provide up to $2,000 of additional financing to Dahae under the term loan facility.

[**Table of Contents**](#TOC)

The table below presents the summarized transactions recorded in the Condensed Consolidated Balance Sheets related to the Company's equity method investment for the periods presented. The transactions reflected in the table below coupled with the term loan facility of $2,000 represent the maximum loss exposure as a result of the Company's involvement with Dahae at September 30, 2025.

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025** | **December 31, 2024** |
| Bond  | $3202 | $3105 |
| Loan  | 1162 | 1161 |
| Warrants  | 607 | 607 |
| Equity method investment (a)  | 613 | 520 |
| Mezzanine equity | 303 | 34 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The change in equity method investment from December 31, 2024 to September 30, 2025 reflects Dahae's loss of $578 and income of $84 during the three and nine months ended September 30, 2025, respectively. Additionally, the currency translation adjustment for the three and nine months ended September 30, 2025 of $(36) and $9 , respectively related to the conversion from South Korean Won to U.S. dollar.

The table below presents the summarized transactions recorded in the Condensed Consolidated Statements of Operations and Comprehensive Loss related to the Company's equity method investment for the three and nine months ended September 30, 2025 and 2024, respectively.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Interest income  | $76 | $— | $223 | $— |
| Share of net loss of equity method investee | (607) |  | (1) |  |
| Other comprehensive income  | (54) |  | (9) |  |

---

#### Note 13 – Income Taxes
The Company's effective tax rate was (1.44)% and (1.64)% for the three months ended September 30, 2025 and 2024, respectively. The Company's effective tax rate was (0.55)% and (1.34)% for the nine months ended September 30, 2025 and 2024, respectively. The Company was in a full valuation allowance for the nine months ended September 30, 2025 and the year ended December 31, 2024.

The Company's quarterly provision for income taxes is calculated by applying a projected annual effective tax rate, calculated separately for the United States and Republic of Korea, to ordinary pre-tax book income.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA"), was enacted in the United States. The OBBBA includes, among other things the permanent extension of certain provisions of the U.S. Tax Cuts and Jobs Act of 2017, modifications to the United States' international tax framework, restoration of favorable tax treatment for certain business provisions, and acceleration of the phase-out of EV credits. The OBBBA contains a variety of effective dates, with certain provisions effective in 2025 and others implemented through 2027. The OBBA did not have a material impact on the reported results of operations.

**Note 14 – Contingencies**

The Company may be party to litigation from time to time in the normal course of business. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.

On December 3, 2024, two purported stockholders filed a putative class action against the former officers and directors of Decarbonization Plus Acquisition Corporation III ("DCRC"), including Erik Anderson; Riverstone Holdings, LLC; and related sponsors and entities (the "Hamilton Defendants") in the Court of Chancery of the State of Delaware (Hamilton et al. v. Anderson et al., C.A. No. 2024-1241-JTL). The lawsuit alleges breach of fiduciary duties and unjust enrichment arising from the merger of Solid

[**Table of Contents**](#TOC)

Power Operating, Inc. with a subsidiary of DCRC and seeks to recover unspecified damages and equitable relief. None of the Company, its subsidiaries, or its current officers or directors, except Mr. Anderson, is named as a defendant. The Hamilton Defendants have demanded indemnification and advancement of defense costs from the Company. Accordingly, it is reasonably possible that the Company could be liable for the legal fees, defense costs, judgments, and/or settlement fees incurred by certain of the Hamilton Defendants. The proceedings are subject to uncertainties inherent in the litigation process, and the Company cannot currently estimate a reasonably possible loss.

#### Note 15 – Subsequent Events
On October 27, 2025, Solid Power Operating, Inc, BMW AG ("BMW AG"), and Samsung SDI Co., Ltd. ("Samsung SDI") entered into a Joint Evaluation Agreement (the "Joint Evaluation Agreement"). Pursuant to the terms of the Joint Evaluation Agreement, the Company agreed to provide electrolyte to Samsung SDI, which Samsung SDI will use to fabricate separator and/or catholyte and build cells, in each case subject to achievement of technical requirements. Samsung SDI will determine whether the cells satisfy performance parameters and requirements to be agreed between BMW AG and Samsung SDI.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*The following Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the consolidated financial statements and related notes thereto included elsewhere in this Report. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs, and expected performance. For additional discussion, see "Cautionary Note Regarding Forward-Looking Statements" above. The forward-looking statements are dependent upon events, risks, and uncertainties that may be outside of our control. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed elsewhere in this Report, under "Part I, Item 1A. Risk Factors" of the 2024 Form 10-K, and under "Part II, Item 1A. Risk Factors" in the Q2 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. Unless indicated otherwise, the following discussion and analysis of results of operations and financial condition and liquidity relates to our current continuing operations and should be read in conjunction with the consolidated financial statements and notes thereto of this Report and the 2024 Form 10-K. We do not undertake, and expressly disclaim, any obligation to publicly update any forward-looking statements, whether as a result of new information, new developments, or otherwise, except to the extent that such disclosure is required by applicable law.*

**Overview**

Solid Power is a U.S.-based leader in solid-state battery technology and manufacturing processes. Our core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. We believe our electrolyte technology has the potential to enable a step-change improvement in battery cell performance beyond what is currently achievable in conventional lithium-ion battery cells, including improved energy density, battery life, and safety performance. We are currently targeting the battery electric vehicle market due to the size and perceived demand for next generation battery technology but believe our technologies can have a broader application as they mature.

**2025 Development Objectives**

We made progress on our 2025 development objectives as the solid-state battery landscape continues to evolve. Below is a summary of recent progress towards our goals.

● *Drive electrolyte innovation and performance through feedback from cell development and customers*; *ramp electrolyte sampling and identify long-term customers -* We announced a Joint Evaluation Agreement with Samsung SDI Co., Ltd. and BMW AG to progress the development of all-solid-state batteries, marking meaningful progress on our path towards commercialization.

● *Continue executing on our electrolyte development roadma* p – We conducted detailed design for the planned installation of a pilot line designed to manufacture electrolyte on a continuous process. We expect detailed design to be substantially completed by the end of 2025 and remain on track for commissioning of the line in 2026.

[**Table of Contents**](#TOC)

● *Execute on the SK On Agreements* – We conducted site acceptance testing under our line installation agreement with SK On Co., Ltd. ("SK On"). We remain on track for completion of site acceptance testing at SK On's facility by the end of 2025.

● *Remain fiscally disciplined* – We remained fiscally disciplined, balancing financial discipline with appropriate investments in technology developments and process improvements. We also raised net proceeds of $32.9 million through sales of our shares of common stock under an at-the-market offering program (the "ATM"). See "—Results of Operations" and "—Liquidity and Capital Resources" for more information.

**Key Factors Affecting Operating Results**

We are a research and development-stage company and have not generated cash flows through the sale of our electrolyte or licensing of our cell designs to adequately cover our costs. Our ability to commercialize our products depends on several factors that present significant opportunities but also pose material risks and challenges, including those discussed in the "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" sections of this Report, which are incorporated by reference.

Prior to reaching commercialization, we must improve our products to ensure they meet the performance requirements of our customers. We also will have to negotiate commercial agreements with our customers on terms and conditions that are mutually acceptable. To satisfy anticipated demand, we will need to scale production of our electrolyte. All of these will take time, require capital, and affect our operating results. Since many factors are difficult to quantify, our actual operating results may be different than currently anticipated.

Revenue generated to date has primarily come from performance on research and development licensing agreements, line installation agreement, and government contracts. We will need to continue to deploy substantial capital to expand our production capabilities and engage in research and development programs. We also expect to continue to incur administrative expenses as a publicly traded company.

In addition to meeting our development goals, commercialization and future growth and demand for our products are highly dependent upon consumers adopting EVs. The market for new energy vehicles is still rapidly evolving due to emerging technologies, competitive pricing, government regulation and industry standards, and changing consumer demands and behaviors.

#### Basis of Presentation
We currently conduct our business through one operating segment and one reportable segment. As a research and development company with no commercial operations, our activities to date have been limited and were conducted primarily in the United States and the Republic of Korea. Our historical results are reported under U.S. generally accepted accounting principles and in U.S. dollars.

[**Table of Contents**](#TOC)

#### Results of Operations
***Comparison of the Three and Nine Months Ended September 30, 2025 to the Three and Nine Months Ended September 30, 2024***

During the three and nine months ended September 30, 2025, our capital and operational investments supported our key 2025 development objectives.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Change** | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Change** |
|  | **2025** | **2024** | $**%** | **2025** | **2024** | $**%** |
| **Revenues and Grant Income** |  |  |  |  |  |  |
| &nbsp;&nbsp;Revenue | $3732 | $4651 | (20)% | $15342 | $15679 | (2)% |
| &nbsp;&nbsp;Grant income  | 828 |  | 100% | 2774 |  | 100% |
| &nbsp;&nbsp;Total revenue and grant income  | 4560 | 4651 | (2)% | 18116 | 15679 | 16% |
| **Operating Expenses** |  |  |  |  |  |  |
| &nbsp;&nbsp;Direct costs | 3632 | 6973 | (48)% | 14790 | 16700 | (11)% |
| &nbsp;&nbsp;Research and development | 18276 | 17319 | 6% | 55639 | 54718 | 2% |
| &nbsp;&nbsp;Selling, general and administrative | 7074 | 7950 | (11)% | 22008 | 24570 | (10)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 28982 | 32242 | (10)% | 92437 | 95988 | (4)% |
| **Operating Loss** | (24422) | (27591) | (11)% | (74321) | (80309) | (7)% |
| **Nonoperating Income and Expense** |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest income | 3050 | 4251 | (28)% | 9887 | 13707 | (28)% |
| &nbsp;&nbsp;Change in fair value of warrant liabilities | (3464) | 1591 | (318)% | (802) | 1793 | (145)% |
| &nbsp;&nbsp;Interest expense | (6) | (11) | (45)% | (21) | (37) | (43)% |
| &nbsp;&nbsp;Other income (expense) | (58) | (283) | (80)% | (732) | (167) | 338% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total nonoperating income and expense | (478) | 5548 | (109)% | 8332 | 15296 | (46)% |
| **Pretax Loss**  | $**(24900)** | $**(22043)** | **13%** | $**(65989)** | $**(65013)** | **2%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense  | 360 | 376 | (4)% | 365 | 887 | (59)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Share of net loss of equity method investee | 607 |  | 100% | 1 |  | 100% |
| **Net Loss Attributable to Common Stockholders** | $**(25867)** | $**(22419)** | **15%** | $**(66355)** | $**(65900)** | **1%** |
| **Other Comprehensive Income (Loss)** | 161 | 2058 | (92)% | 346 | 1468 | (76)% |
| **Comprehensive Loss Attributable to Common Stockholders** | $**(25706)** | $**(20361)** | **26%** | $**(66009)** | $**(64432)** | **2%** |

---

***Revenue and Grant Income***

Revenue recognized consists of performance on our non-government contracts as well as certain government contracts. Grant income recognized consists of performance on our assistance agreement, dated January 1, 2025 (as amended effective May 15, 2025, the "Assistance Agreement"), with the U.S. Department of Energy ("DOE").

Revenue and grant income remained consistent with a $0.1 million decrease for three months ended September 30, 2025 compared to the three months ended September 30, 2024. Revenue and grant income increased $2.4 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 primarily driven by the performance on our Assistance Agreement in the nine months ended September 30, 2025.

[**Table of Contents**](#TOC)

We recognized $3.0 million and $13.4 million of collaborative revenue for the three and nine months ended September 30, 2025, respectively. The collaborative revenue primarily consists of performance on our research and development technology license agreement, line installation agreement, and electrolyte supply agreement with SK On (collectively, the "SK On Agreements"). During the three months ended September 30, 2025, we conducted site acceptance testing of the SK On line under the line installation agreement. We plan to complete site acceptance testing by the end of this year, which would result in additional revenue recognition.

We recognized $1.6 million and $4.7 million of government revenue and government grant income for the three and nine months ended September 30, 2025, respectively. Government revenue and government grant income consisted primarily of grant income from the Assistance Agreement. The Assistance Agreement stipulates that the DOE will provide us with funding of up to $50 million for our installation of equipment necessary for the continuous production of sulfide-based solid electrolyte material. During the three and nine months ended September 30, 2025, we continued developing the detailed design of the continuous electrolyte production pilot line. Grant income is recognized on the non-capital costs of the project. As we continue to execute on the project milestones, we expect to recognize additional grant income.

***Operating Expenses***

Operating expenses decreased $3.3 million in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 primarily due to direct costs related to initial design costs associated with the line installation agreement with SK On in the period ended September 30, 2024. Operating expenses decreased $3.6 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 attributable to decreases in our direct costs as well as selling, general and administrative costs.

*Direct Costs*

Direct costs decreased $3.3 million for the three months ended September 30, 2025 compared to the same period in 2024 due to timing of achievements of milestones under our collaboration agreements. Executing on the milestones under our collaboration agreements required greater investments in 2024 than in the same period ended in 2025. In the three months ended September 30, 2025, we incurred $2.1 million in services and equipment provided by Dahae Energy Co., Ltd. ("Dahae"), a strategic partner serving as installer of the SK On line. Costs this period included material and internal labor to support site acceptance testing under the line installation agreement.

Direct costs decreased $1.9 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 mostly due to a decrease in services and equipment provided by Dahae in the nine months ended September 30, 2025 compared to the same period in the prior year.

We expect an increase in direct costs corresponding to our revenue growth as we complete site acceptance testing of the line at SK On's facility this year and continue to execute on the construction of the project milestones supporting our continuous electrolyte production pilot line.

*Research and Development*

Research and development-related operating expenses largely consisted of employee compensation and employee benefit costs incurred to maintain our skilled workforce, including engineers, scientists, operators, chemists, and technicians. Total research and development costs increased $1.0 million and $0.9 million in the three and nine months ended September 30, 2025, respectively, compared to the same periods ended September 30, 2024 due to an $0.8 million patent impairment loss in the three months ended September 30, 2025. Aside from this impairment loss, research and development costs remained consistent.

*Selling, General and Administrative* 

Selling, general and administrative expenses are largely comprised of employee compensation and personnel related costs for our administrative functions as well as costs driven by insurance and regulatory requirements. Selling, general and administrative expenses decreased by $0.9 million and $2.6 million in the three and nine months ended September 30, 2025, respectively, compared to the same periods ended September 30, 2024 largely due to a decrease in stock-based compensation expense as a result of forfeitures of unvested stock options and restricted stock units. The decrease of selling, general and administrative expenses was also driven by the strategic decision to reduce contractor and consultant support.

Overall, we expect operating expenses for the remainder of the year to decrease as we continue to execute on our objectives and focus on cost reduction efforts to offset overall rising costs.

[**Table of Contents**](#TOC)

***Nonoperating Income and Expense***

Nonoperating income and expense includes interest income, the non-cash impact from the change in the fair value of our warrant liabilities and other immaterial income and expense items.

For the three months ended September 30, 2025, nonoperating income and expense decreased $6.1 million compared to the three months ended September 30, 2024 due to both the change in fair value of the warrant liabilities as well as the change in interest income earned. Interest income earned decreased $1.2 million for the three months ended September 30, 2025 due to a reduction in the total available-for-sale securities available to earn interest compared to prior year. The change in the fair value of the warrant liabilities for the three months ended September 30, 2025 caused a $3.5 million loss compared to the three months ended September 30, 2024 where the change in the fair value caused a gain of $1.6 million. The impact of these changes caused a period-over-period loss in the fair value of warrant liabilities of $5.1 million.

For the nine months ended September 30, 2025, nonoperating income and expense decreased $7.0 million compared to the nine months ended September 30, 2024 due to both the change in fair value of the warrant liabilities as well as the change in interest income earned. Interest income earned decreased $3.8 million for the nine months ended September 30, 2025 compared to the same period in 2024 due to a reduction in the total available-for-sale securities available to earn interest. The change in the fair value of the warrant liabilities for the nine months ended September 30, 2025 caused a $0.8 million loss compared to the nine months ended September 30, 2024 where the change in the fair value caused gain of $1.8 million. The impact of these changes caused a period-over-period loss in the fair value of warrant liabilities of $2.6 million.

**Liquidity and Capital Resources**

*Sources of Liquidity*

The sale of equity has historically been our primary source of cash, with a smaller portion of cash coming from achievement of performance milestones under agreements with our partners and government contracts. We also receive cash from the interest earned on our available-for-sale securities.

As of September 30, 2025 and December 31, 2024, we had total liquidity, as set forth below:

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **September 30, 2025** | **December 31, 2024** |
| Cash and cash equivalents | $47286 | $25413 |
| Available-for-sale securities  | 253141 | 302057 |
| **Total liquidity** | $300427 | $327470 |

---

As of September 30, 2025 total liquidity, which includes all cash and cash equivalents as well as our available-for-sale securities, was $300.4 million, a decrease of $27.0 million compared to December 31, 2024. As of September 30, 2025, contract assets and contract receivables were $7.2 million and total current liabilities were $16.6 million.

Short-Term Liquidity Requirements

Our short-term liquidity requirements include operating and capital expenses needed to further our research and development programs and to install our continuous electrolyte production pilot line. We anticipate that our most significant capital expenditures for the remainder of the year will relate to facility engineering and construction of our continuous electrolyte production pilot line as well as improvements to our cell development capabilities. We believe that our cash on hand is sufficient to meet our operating cash needs and working capital and capital expenditure requirements for a period of at least the next 12 months.

*Long-Term Liquidity Requirements*

Longer term, we may require additional liquidity prior to being able to generate adequate cash flows from electrolyte sales and/or licensing activities. We also may require funding if there are material changes to our business conditions or other developments, including changes to our operating plan; development progress or delays; negotiations with OEMs, cell manufacturers, or other customers; market adoption of EVs; supply chain challenges; competitive pressures; government regulations, including tariffs; and inflation. To the extent that our resources, including our ability to use the ATM to generate additional proceeds, are insufficient to satisfy our cash requirements, we may need to seek equity or debt financing. We also may opportunistically seek to

[**Table of Contents**](#TOC)

enhance our liquidity through equity or debt financing, if such financing becomes available to us on terms that we consider favorable. If financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, which may adversely affect our development, business, operating results, financial condition and prospects.

*At-the-Market Offering*

On September 5, 2025, we entered into an Equity Distribution Agreement (the "Distribution Agreement") with Oppenheimer & Co. Inc., serving as agent ("Oppenheimer"), with respect to the ATM under which we may offer and sell, from time to time, shares of our common stock having an aggregate offering price of up to $150.0 million through Oppenheimer.

During the three months ended September 30, 2025, we sold 8,471,849 shares of common stock at an average price of $4.02 per share raising gross proceeds of $34.1 million before deducting offering costs, commissions, and fees. Our net proceeds totaled $32.9 million. We intend to use the net proceeds from shares offered and sold under the ATM for working capital and general corporate purposes.

As of September 30, 2025, approximately $115.9 million remained available for future sales under the Distribution Agreement.

*Stock Repurchase Program* 

On January 23, 2024, we announced that our Board approved a stock repurchase program authorizing us to purchase up to $50 million of our outstanding common stock. Under the stock repurchase program, we may purchase shares of our common stock from time to time until the repurchase program expires on December 31, 2025. The shares of common stock may be purchased on the open market, in unsolicited negotiated transactions, or in any manner that complies with the provisions of Rule 10b-18 of the Exchange Act. Management's decision to repurchase shares of common stock will depend on a number of factors, such as the price of the common stock, economic and market conditions, and corporate and regulatory requirements. During the nine months ended September 30, 2025, we repurchased 3,361,396 shares of common stock at an average price of $1.05 per share for an aggregate cost excluding commissions of approximately $3.53 million. During the nine months ended September 30, 2024, we repurchased 5,000,000 shares of common stock at an average price of $1.63 per share for an aggregate cost of approximately $8.27 million.

*Cash Flows*

The following table summarizes our cash flows from operating, investing, and financing activities for the periods presented:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
| **(in thousands)** | **2025** | **2024** |
| Net cash and cash equivalents used in operating activities | $(55002) | $(50030) |
| Net cash and cash equivalents provided by investing activities | $46099 | $62139 |
| Net cash and cash equivalents provided by (used in) financing activities | $30776 | $(8677) |

---

*Cash used in operating activities:*

Cash used in operating activities for the nine months ended September 30, 2025 increased $5.0 million compared to the nine months ended September 30, 2024 primarily driven by a decrease in cash received from our partners in the period ending September 30, 2025. We received $12.1 million of cash from our partners in the nine months ended September 30, 2025, compared to $20.4 million of cash received from our partners in the nine months ended September 30, 2024. The cash received from partners is paid based on achievement of milestones and will change based on the timing of those milestone payments and the payment terms in our arrangements.

Cash used for operations independent of cash received from our partners decreased $3.3 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 mainly due to a decrease in cash used for payments to Dahae for services, equipment and supplies. Cash used for payments to Dahae were $5.3 million in the nine months ended September 30, 2025 compared to $8.2 million in the nine months ended September 30, 2024. This change is due to the timing of milestone payments under our agreement with Dahae in connection with the SK On arrangement.

[**Table of Contents**](#TOC)

Cash used for employee compensation and other employee benefit related costs, including the payout of annual performance-based incentive compensation, totaled $31.3 million in the nine months ended September 30, 2025 compared to $33.7 million for the same period in prior year. The remaining cash used in operating activities for the nine months ended September 30, 2025 were costs to operate our facilities, purchases of materials and supplies, and hazardous waste removal. We anticipate cash used in operations for the remainder of the year to remain consistent, with decreased cash receipts from partners partially offsetting decreased cash used for expenses.

*Cash provided by investing activities:*

Cash provided by investing activities decreased by $16.0 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 due to the change in the activity on our proceeds and purchases of our available-for-sale securities, change in capital expenditures, and cash used for loan receivables.

Proceeds from our available-for-sale security activity decreased $25.8 million in the nine months ending September 30, 2025 compared to the same period in prior year. This change was due to the timing of the individual security maturity date and the sale of fewer securities in the nine months ended September 30, 2025 compared to the same period in 2024.

Cash used for capital expenditures and intangibles decreased $5.3 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. Capital expenditures in 2025 were primarily for the construction of our continuous electrolyte production pilot line. Cash used for capital expenditures for the same period in 2024 was for construction of our Electrolyte Innovation Center, or EIC. Capital expenditures for the nine months ended September 30, 2025 totaled $8.1 million partially offset by cash received of $2.5 million from the DOE under the Assistance Agreement. We anticipate cash used in investing for capital expenditures for the remainder of the year to increase as we continue to make progress toward the installation of the continuous electrolyte production pilot line.

Cash paid for a loan receivable from our equity method investee, Dahae, was $0 in the nine months ended September 30, 2025 and $4.5 million in the nine months ended September 30, 2024.

*Cash provided by financing activities:*

Cash provided by financing activities increased $39.5 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was primarily due to receipt of $32.9 million of proceeds, net of offering costs, commissions, and fees, for the sale of shares of our common stock under the Distribution Agreement. Cash used in our stock repurchase program decreased $4.7 million in the nine months ended September 30, 2025 compared to nine months ended September 30, 2024. We repurchased $3.6 million of our stock under the stock repurchase program in the nine months ended September 30, 2025 compared to $8.3 million of our common stock in the nine months ended September 30, 2024. The remaining cash used in financing activities for the nine months ended September 30, 2025 was cash paid for withholding of employee taxes related to stock-based compensation and payments on finance lease liabilities, partially offset by proceeds from the exercise of stock options.

**Off-Balance Sheet Arrangements**

We are not a party to any off-balance sheet arrangements, as defined under SEC rules.

[**Table of Contents**](#TOC)

**Critical Accounting Estimates**

Except as set forth below, there have been no significant and material changes in our critical accounting policies and use of estimates during the nine months ended September 30, 2025 as compared to those disclosed in "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates" in the 2024 Form 10-K.

---

| | | |
|:---|:---|:---|
| **Collaborative Revenue** | **Collaborative Revenue** | **Collaborative Revenue** |
| **Description** | **Judgments and Uncertainties**  | **Effect if Results Differ From Assumptions**  |
| We recognize revenue from our research and development collaboration agreements representing joint operating activities in accordance with ASC 808 – Collaborative Arrangements. These agreements include the following components: parties to the contract are active participants, both parties are exposed to significant risks and rewards, and both parties are dependent on the commercial success of the efforts under the contract.  | Our revenue recognition accounting methodology requires us to make significant estimates and assumptions, and to apply professional judgment.<br>Prior to January 1, 2025, our collaborative arrangements were recognized using the input measurement method utilizing labor hours in relation to total labor hours anticipated to satisfy the performance obligation. As of January 1, 2025, our collaborative arrangements recognize revenue over time using the input measurement method utilizing the cost-to-cost method to satisfy the combined performance obligation.<br>Contract costs include all direct labor, subcontract costs, costs for materials and indirect costs related to the contract performance that are allowable under the provisions of the contract. Collaborative revenues from fee-based contracts are recognized based on costs incurred to meet contractually defined milestones and deliverables along with our assessment of achievement of those measurable deliverables under the contract or based on appropriate over time methods.<br>| If we were to change our judgments or estimates, it could cause a material increase or decrease in the amount of revenue or deferred revenue that we report in a particular period.  |

---

**Recent Accounting Pronouncements**

See Note 2 of our unaudited financial statements included in this Report as well as Note 2 of our audited financial statements included in the 2024 Form 10-K for more information.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

[**Table of Contents**](#TOC)

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired controls. As required by Rule 13a-15(b) under the Exchange Act, our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025.

Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective.

**Changes in Internal Control Over Financial Reporting**

There was no change in our internal control over financial reporting that occurred during the three months ended September 30, 2025 covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II – OTHER INFORMATION**

**Item 1. Legal Proceedings**

From time to time, we have been, and may become, involved in litigation or other legal proceedings. See Note [14] of our unaudited financial statements included in this Report for more information. Regardless of outcome, litigation, including indemnity claims, can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

**Item 1A. Risk Factors**

Our business, prospects, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be affected by a number of factors, whether currently known or unknown, including those described in "Part I, Item 1A. Risk Factors" of the 2024 Form 10-K and "Part II, Item 1A. Risk Factors" of the Q2 Form 10-Q, as such descriptions may be updated or amended in future filings we make with the SEC. When any one or more of these risks materialize from time to time, our business, reputation, results of operations and financial condition, as well as the price of our common stock and warrants, can be materially and adversely affected. There have been no material changes to our risk factors since the Q2 Form 10-Q.

[**Table of Contents**](#TOC)

**Item 6. Exhibits**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** |
| <br>**Exhibit**<br>**Number** | <br>**Description** | **Schedule Form** | **File Number** | **Exhibit/Annex** | **Filing Date** |
| 3.1 | [Second Amended and Restated Certificate of Incorporation](https://www.sec.gov/Archives/edgar/data/1844862/000110465921148821/tm2132574d4_ex3-1.htm) | 8-K | 001-40284 | 3.1 | December 13, 2021 |
| 3.2 | [Amended and Restated Bylaws](https://www.sec.gov/Archives/edgar/data/1844862/000110465922120761/tm2230910d2_ex3-1.htm) | 8-K | 001-40284 | 3.1 | November 21, 2022 |
| 10.1 | [Equity Distribution Agreement, dated September 5, 2025, by and between Solid Power, Inc. and Oppenheimer & Co. Inc.](https://www.sec.gov/Archives/edgar/data/1844862/000110465925087907/tm2525177d3_ex1-1.htm) | 8-K | 001-40284 | 1.1 | September 5, 2025 |
| 31.1\* | [Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](sldp-20250930xex31d1.htm) |  |  |  |  |
| 31.2\* | [Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](sldp-20250930xex31d2.htm) |  |  |  |  |
| 32.1\*\* | [Section 1350 Certification](sldp-20250930xex32d1.htm) |  |  |  |  |
| 32.2\*\* | [Section 1350 Certification](sldp-20250930xex32d2.htm) |  |  |  |  |
| 101.INS\* | XBRL Instance Document – the instance document does not appear in the Interactive Data file because its Inline XBRL tags are embedded within the Inline XBRL document. |  |  |  |  |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document |  |  |  |  |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase |  |  |  |  |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Document |  |  |  |  |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  |  |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase |  |  |  |  |
| 104\* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |  |

---

\* Filed herewith.

\*\* Furnished herewith.

[**Table of Contents**](#TOC)

**SIGNATURE**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Date: November 5, 2025 | **Solid Power, Inc.** |

---

---

| | |
|:---|:---|
| By: | /s/ John Van Scoter |
| Name: | John Van Scoter |
| Title: | President, Chief Executive Officer, and Director |
| *(Principal Executive Officer)* | *(Principal Executive Officer)* |

---

---

| | |
|:---|:---|
| By: | /s/ Linda Heller |
| Name:  | Linda Heller |
| Title:  | Chief Financial Officer, Treasurer, and Secretary |
| *(Principal Financial and Accounting Officer)* | *(Principal Financial and Accounting Officer)* |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION**

**302 OF THE SARBANES-OXLEY ACT OF 2002**

I, John Van Scoter, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Solid Power, Inc. for the quarterly period ended September 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 |  |  |
|  | By: | /s/ John Van Scoter |
|  | John Van Scoter | John Van Scoter |
|  | President and Chief Executive Officer | President and Chief Executive Officer |
|  | *(Principal Executive Officer)* | *(Principal Executive Officer)* |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION**

**302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Linda Heller, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Solid Power, Inc. for the quarterly period ended September 30, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 |  |  |
|  | By: | /s/ Linda Heller |
|  | Linda Heller | Linda Heller |
|  | Chief Financial Officer, Treasurer, and Secretary | Chief Financial Officer, Treasurer, and Secretary |
|  | *(Principal Financial and Accounting Officer)* | *(Principal Financial and Accounting Officer)* |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Solid Power, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, to the best of my knowledge, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 |  |  |
|  | By: | /s/ John Van Scoter |
|  | John Van Scoter | John Van Scoter |
|  | President and Chief Executive Officer | President and Chief Executive Officer |
|  | *(Principal Executive Officer)* | *(Principal Executive Officer)* |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**<br>**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**<br>**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Solid Power, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, to the best of my knowledge, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 5, 2025 |  |  |
|  | By: | /s/ Linda Heller |
|  | Linda Heller | Linda Heller |
|  | Chief Financial Officer, Treasurer, and Secretary | Chief Financial Officer, Treasurer, and Secretary |
|  | *(Principal Financial and Accounting Officer)* | *(Principal Financial and Accounting Officer)* |

---

------